Combining CRISPR with Flow-FISH to study CRISPR-mediated genome perturbation

IF 2.5 4区 生物学 Q3 BIOCHEMICAL RESEARCH METHODS Cytometry Part A Pub Date : 2023-12-06 DOI:10.1002/cyto.a.24815
Julian J. Freen-van Heeren
{"title":"Combining CRISPR with Flow-FISH to study CRISPR-mediated genome perturbation","authors":"Julian J. Freen-van Heeren","doi":"10.1002/cyto.a.24815","DOIUrl":null,"url":null,"abstract":"<p>Since the advent of the clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated (Cas) system as a genome editing tool, the ease of studying gene function and the impact thereof on cellular function has increased incrementally. Not surprisingly, the original describers of the CRISPR/Cas system received the 2020 Nobel Prize in Chemistry. Compared to conventional genome editing tools such as Transcription Activator-Like Effector Nucleases (TALENs) or Zinc Finger Nucleases (ZFNs), CRISPR is a more versatile platform that can be easily adjusted to target new genes of interest.</p><p>The mechanism behind genome editing by the CRISPR/Cas9 system has been recently thoroughly reviewed elsewhere [<span>1</span>]. Briefly, CRISPR-mediated genome editing is dependent on at least two components: (1) a Cas protein that possesses endonuclease activity and (2) a variable ~20 base pair nucleic-acid based targeting crisprRNA (crRNA) that defines the target of interest. Depending on the type of Cas protein employed, also a trans-activating RNA (tracrRNA) is required in order to activate nuclease activity. Together, the gRNA and tracrRNA are often referred to as the single guide RNA, or sgRNA. Additionally, nuclease activity only occurs in the context of a protospacer adjacent motive (PAM)—a specific 3–5 nucleotide sequence that is specific to the Cas-molecule employed, further enhancing on-target specificity. Indeed, the PAM and the gene-specific targeting gRNA together define the genomic locus of interest that is targeted for double-stranded cleavage. Subsequent inefficient DNA repair machinery introduces mutations, often disabling the gene of interest in the process [<span>2</span>]. To ensure knock-out, the gene of interest can also be targeted with two specific gRNAs, resulting in deletion of a specific piece of (non-)coding genomic information [<span>3</span>]. CRISPR/Cas-mediated genome editing can also be used to introduce a specific mutation of interest or partial gene replacement by making use of a donor repair template [<span>4</span>], often referred to as a homology-directed repair template after the cellular process that is exploited to facilitate this.</p><p>Together, these characteristics have made the CRISPR/Cas system the genome editing tool of choice for many (molecular) biologists. However, in order to validate gene knock-out or the effect thereof, researchers still often rely on (genome) sequencing data, after which knock-out cells are no longer viable nor usable in experimentation, providing only information on a genomic or RNA level. When knock-out efficiency is suboptimal, the resulting data set may be confounded unless single cell RNA sequencing has been performed. However, these types of data are both often costly and require a high level of expertise to analyze. Therefore, expanding the CRISPR toolbox with other tools that allow for visualization of gene alterations, or their influence on other genes, is highly desirable. Optimally, such a tool should be high-throughput.</p><p>One technique that might be suitable for this purpose is fluorescence in situ hybridization (FISH). FISH makes use of fluorescently labeled nucleic acid probes that specifically recognize DNA sequences in order to identify either loci of interest or a specific mRNA species to study the expression of a gene of interest. FISH and CRISPR-mediated genome editing have already been combined as a research tool [<span>5</span>]. Furthermore, FISH is also suitable for use in flow cytometry (also known as Flow-FISH), allowing for high-throughput and multi-parameter measurements, especially when employing fluorescent antibodies to detect protein levels in addition to mRNA/nucleotide sequences [<span>6, 7</span>].</p><p>One application where CRISPR and Flow-FISH work complementary is telomere Flow-FISH. This type of approach allows for direct characterization of the impact of genetic perturbations on telomere length, which is reflective of cellular health and longevity. In several studies, authors investigated factors that control telomere length. In one study, the role of RAP1, a well-known telomere binding protein with unknown function, was unraveled. After CRISPR/Cas9-mediated knock-out of RAP1, flow cytometric assessment of telomeres via Flow-FISH revealed that RAP1 knock-out cells exhibit longer telomeres [<span>5</span>]. However, this could also be assessed with other techniques. Indeed, the real benefit of combining CRISPR/Cas-mediated genome editing and Flow-FISH was shown in another study, where authors employed a CRISPR-based screening approach. After library-based knock-out, cells were screened with telomere Flow-FISH to sort out the 5% highest telomere-possessing population, and the 5% lowest telomere-possessing population. From their hits, they identified SAMHD1 as a negative regulator of telomere length, and thymidylate synthase, or TYMS, as a positive regulator. Interestingly, supplementing cells with thymidine, the substrate for TYMS, also robustly drove telomere elongation. This was also true for patients with telomere-related disorders: inhibiting SAMHD1 or addition of thymidine resulted in telomere restoration [<span>8</span>]. Together, these data might result in new treatment strategies.</p><p>Flow-FISH is not restricted to use in eukaryotes, but can also be used to probe gene expression in (pathogenic) microbes [<span>9</span>]. This can be of particular interest in rapidly mutating organisms such as SARS-CoV-2 [<span>10</span>], as designing new FISH probe sets is significantly easier than producing novel protein-targeting antibodies that recognize the mutated protein. Indeed, Flow-FISH and CRISPR have been employed together to investigate potential therapeutic targets in SARS-CoV-2 [<span>11</span>]. Authors hypothesized that SARS-CoV-2 infected cells undergo metabolic changes to facilitate virion production. Specifically, for RNA synthesis, next to glucose, also one-carbon units derived from folate species are required. By inhibiting one-carbon metabolism with methotrexate, SARS-CoV-2 nucleocapsid RNA expression was significantly reduced in infected cells as measured by Flow-FISH. Next, authors investigated the role of serine hydroxymethyltransferase 1 and 2 (SHMT1 and SHMT2), two metabolic enzymes that play a role in one-carbon folate species generation. By treating SARS-CoV-2 infected cells with an SHMT1/2 dual inhibitor, SARS-CoV-2 Nucleocapsid RNA expression in infected cells as determined with Flow-FISH was diminished. To further identify whether both SHMT1 and SHMT2 play a role, authors knocked out both proteins with CRISPR. Interestingly, while both SHMT1 and SHMT2 facilitate one-carbon metabolism, only SHMT1 knock-out reduced the expression of SARS-CoV-2 nucleoprotein RNA and protein. Together, this data show that Flow-FISH can be used to unravel the effects of CRISPR-mediated knock-outs, and can result in druggable targets.</p><p>Besides facilitating easy gene targeting, the advent of the CRISPR/Cas9 technology also empowered large scale screens. This type of approach is often followed by some type of sequencing approach. One way to streamline this process is to employ Flow-FISH for sorting populations based on gene expression. Indeed, Gjaltema et al combined a large-scale CRISPR screen with Flow-FISH to study the complex regulation surrounding <i>Xist</i>, a developmental gene [<span>12</span>]. Authors used a pooled CRISPR interference approach to identify <i>Xist</i>-controlling regulatory elements. Here, authors employed a catalytically inactive Cas9 protein fused to a KRAB repressor domain, resulting in the targeted inhibition of putative regulatory elements. Subsequently, authors employed <i>Xist</i> Flow-FISH to sort out cells expressing no <i>Xist</i>, or low, medium, or high <i>Xist</i> expression, respectively. After deep sequencing of the sorted populations, authors were able to identify gRNAs that influenced <i>Xist</i> expression. Besides known regulatory elements, they also identified novel regulating regions. The data gathered by Gjaltema et al show how complex regulatory elements integrate and generate complex gene expression patterns. Recently, authors also released a methods-style paper, allowing other labs to use this powerful technology to further their own research goals [<span>13</span>].</p><p>Of note, regulatory elements do not necessarily have to be proximal elements. Recently, by combining large-scale CRISPR pools and Flow-FISH, Reilly et al showed that <i>cis</i>-regulatory elements can skip over the nearest gene, and regulate activating and/or silencing effects on neighboring genes. As a proof of concept, they further delineate cis-regulatory elements at the <i>FADS</i> locus, and more importantly, their targets [<span>14</span>]. Furthermore, based on similar data from CRISPR/Flow-FISH experiments, a model has been constructed that allows for mapping enhancer-gene interactions and is suitable for predicting interaction also in cells that are difficult to manipulate via CRISPR/Cas-mediated genome editing [<span>15</span>]. A follow up study by the same group used the same approach to link enhancer variants to disease risk in inflammatory bowel disease [<span>16</span>].</p><p>Together, these studies highlight how combining Flow-FISH and CRISPR/Cas9-mediated genome editing is of use in diverse fields of study, ranging from gene regulation to applications in anti-viral approaches (Figure 1). Indeed, the advent of CRISPR/Cas-mediated genome editing has allowed researchers to investigate both the function of particular genes of interest to minute detail, and empowered research by facilitating large-scale screens. By coupling CRISPR/Cas-mediated genome editing to other tools, such as Flow-FISH, novel insights have been gained into basic cellular processes, the way infections like SARS-CoV-2 rewire cellular metabolism, and the complex network of interactions of <i>cis</i>-regulatory elements and their target genes. Other potential applications could include screening for CRISPR repair efficiency by making use of template-specific probes, or assessing the effector function of tumor infiltrating lymphocyte products with Flow-FISH [<span>17</span>] after CRISPR-mediated genome editing [<span>18</span>]. However, while using e.g. Flow-FISH to sort for cells expressing the target or interacting gene can be useful, sorting should be done in an unbiased manner. Similarly, as the amount of data produced when performing such experiments is also of a great magnitude, data analysis should be carefully considered. For this, computerized models such as Mean Alterations Using Discrete Expression (MAUDE) could be employed [<span>19</span>].</p><p><b>Julian J. Freen-van Heeren:</b> Conceptualization; investigation; writing – original draft; writing – review and editing; project administration; visualization.</p><p>The author declares no conflicts of interest.</p>","PeriodicalId":11068,"journal":{"name":"Cytometry Part A","volume":"105 1","pages":"7-9"},"PeriodicalIF":2.5000,"publicationDate":"2023-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cyto.a.24815","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cytometry Part A","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cyto.a.24815","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Since the advent of the clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated (Cas) system as a genome editing tool, the ease of studying gene function and the impact thereof on cellular function has increased incrementally. Not surprisingly, the original describers of the CRISPR/Cas system received the 2020 Nobel Prize in Chemistry. Compared to conventional genome editing tools such as Transcription Activator-Like Effector Nucleases (TALENs) or Zinc Finger Nucleases (ZFNs), CRISPR is a more versatile platform that can be easily adjusted to target new genes of interest.

The mechanism behind genome editing by the CRISPR/Cas9 system has been recently thoroughly reviewed elsewhere [1]. Briefly, CRISPR-mediated genome editing is dependent on at least two components: (1) a Cas protein that possesses endonuclease activity and (2) a variable ~20 base pair nucleic-acid based targeting crisprRNA (crRNA) that defines the target of interest. Depending on the type of Cas protein employed, also a trans-activating RNA (tracrRNA) is required in order to activate nuclease activity. Together, the gRNA and tracrRNA are often referred to as the single guide RNA, or sgRNA. Additionally, nuclease activity only occurs in the context of a protospacer adjacent motive (PAM)—a specific 3–5 nucleotide sequence that is specific to the Cas-molecule employed, further enhancing on-target specificity. Indeed, the PAM and the gene-specific targeting gRNA together define the genomic locus of interest that is targeted for double-stranded cleavage. Subsequent inefficient DNA repair machinery introduces mutations, often disabling the gene of interest in the process [2]. To ensure knock-out, the gene of interest can also be targeted with two specific gRNAs, resulting in deletion of a specific piece of (non-)coding genomic information [3]. CRISPR/Cas-mediated genome editing can also be used to introduce a specific mutation of interest or partial gene replacement by making use of a donor repair template [4], often referred to as a homology-directed repair template after the cellular process that is exploited to facilitate this.

Together, these characteristics have made the CRISPR/Cas system the genome editing tool of choice for many (molecular) biologists. However, in order to validate gene knock-out or the effect thereof, researchers still often rely on (genome) sequencing data, after which knock-out cells are no longer viable nor usable in experimentation, providing only information on a genomic or RNA level. When knock-out efficiency is suboptimal, the resulting data set may be confounded unless single cell RNA sequencing has been performed. However, these types of data are both often costly and require a high level of expertise to analyze. Therefore, expanding the CRISPR toolbox with other tools that allow for visualization of gene alterations, or their influence on other genes, is highly desirable. Optimally, such a tool should be high-throughput.

One technique that might be suitable for this purpose is fluorescence in situ hybridization (FISH). FISH makes use of fluorescently labeled nucleic acid probes that specifically recognize DNA sequences in order to identify either loci of interest or a specific mRNA species to study the expression of a gene of interest. FISH and CRISPR-mediated genome editing have already been combined as a research tool [5]. Furthermore, FISH is also suitable for use in flow cytometry (also known as Flow-FISH), allowing for high-throughput and multi-parameter measurements, especially when employing fluorescent antibodies to detect protein levels in addition to mRNA/nucleotide sequences [6, 7].

One application where CRISPR and Flow-FISH work complementary is telomere Flow-FISH. This type of approach allows for direct characterization of the impact of genetic perturbations on telomere length, which is reflective of cellular health and longevity. In several studies, authors investigated factors that control telomere length. In one study, the role of RAP1, a well-known telomere binding protein with unknown function, was unraveled. After CRISPR/Cas9-mediated knock-out of RAP1, flow cytometric assessment of telomeres via Flow-FISH revealed that RAP1 knock-out cells exhibit longer telomeres [5]. However, this could also be assessed with other techniques. Indeed, the real benefit of combining CRISPR/Cas-mediated genome editing and Flow-FISH was shown in another study, where authors employed a CRISPR-based screening approach. After library-based knock-out, cells were screened with telomere Flow-FISH to sort out the 5% highest telomere-possessing population, and the 5% lowest telomere-possessing population. From their hits, they identified SAMHD1 as a negative regulator of telomere length, and thymidylate synthase, or TYMS, as a positive regulator. Interestingly, supplementing cells with thymidine, the substrate for TYMS, also robustly drove telomere elongation. This was also true for patients with telomere-related disorders: inhibiting SAMHD1 or addition of thymidine resulted in telomere restoration [8]. Together, these data might result in new treatment strategies.

Flow-FISH is not restricted to use in eukaryotes, but can also be used to probe gene expression in (pathogenic) microbes [9]. This can be of particular interest in rapidly mutating organisms such as SARS-CoV-2 [10], as designing new FISH probe sets is significantly easier than producing novel protein-targeting antibodies that recognize the mutated protein. Indeed, Flow-FISH and CRISPR have been employed together to investigate potential therapeutic targets in SARS-CoV-2 [11]. Authors hypothesized that SARS-CoV-2 infected cells undergo metabolic changes to facilitate virion production. Specifically, for RNA synthesis, next to glucose, also one-carbon units derived from folate species are required. By inhibiting one-carbon metabolism with methotrexate, SARS-CoV-2 nucleocapsid RNA expression was significantly reduced in infected cells as measured by Flow-FISH. Next, authors investigated the role of serine hydroxymethyltransferase 1 and 2 (SHMT1 and SHMT2), two metabolic enzymes that play a role in one-carbon folate species generation. By treating SARS-CoV-2 infected cells with an SHMT1/2 dual inhibitor, SARS-CoV-2 Nucleocapsid RNA expression in infected cells as determined with Flow-FISH was diminished. To further identify whether both SHMT1 and SHMT2 play a role, authors knocked out both proteins with CRISPR. Interestingly, while both SHMT1 and SHMT2 facilitate one-carbon metabolism, only SHMT1 knock-out reduced the expression of SARS-CoV-2 nucleoprotein RNA and protein. Together, this data show that Flow-FISH can be used to unravel the effects of CRISPR-mediated knock-outs, and can result in druggable targets.

Besides facilitating easy gene targeting, the advent of the CRISPR/Cas9 technology also empowered large scale screens. This type of approach is often followed by some type of sequencing approach. One way to streamline this process is to employ Flow-FISH for sorting populations based on gene expression. Indeed, Gjaltema et al combined a large-scale CRISPR screen with Flow-FISH to study the complex regulation surrounding Xist, a developmental gene [12]. Authors used a pooled CRISPR interference approach to identify Xist-controlling regulatory elements. Here, authors employed a catalytically inactive Cas9 protein fused to a KRAB repressor domain, resulting in the targeted inhibition of putative regulatory elements. Subsequently, authors employed Xist Flow-FISH to sort out cells expressing no Xist, or low, medium, or high Xist expression, respectively. After deep sequencing of the sorted populations, authors were able to identify gRNAs that influenced Xist expression. Besides known regulatory elements, they also identified novel regulating regions. The data gathered by Gjaltema et al show how complex regulatory elements integrate and generate complex gene expression patterns. Recently, authors also released a methods-style paper, allowing other labs to use this powerful technology to further their own research goals [13].

Of note, regulatory elements do not necessarily have to be proximal elements. Recently, by combining large-scale CRISPR pools and Flow-FISH, Reilly et al showed that cis-regulatory elements can skip over the nearest gene, and regulate activating and/or silencing effects on neighboring genes. As a proof of concept, they further delineate cis-regulatory elements at the FADS locus, and more importantly, their targets [14]. Furthermore, based on similar data from CRISPR/Flow-FISH experiments, a model has been constructed that allows for mapping enhancer-gene interactions and is suitable for predicting interaction also in cells that are difficult to manipulate via CRISPR/Cas-mediated genome editing [15]. A follow up study by the same group used the same approach to link enhancer variants to disease risk in inflammatory bowel disease [16].

Together, these studies highlight how combining Flow-FISH and CRISPR/Cas9-mediated genome editing is of use in diverse fields of study, ranging from gene regulation to applications in anti-viral approaches (Figure 1). Indeed, the advent of CRISPR/Cas-mediated genome editing has allowed researchers to investigate both the function of particular genes of interest to minute detail, and empowered research by facilitating large-scale screens. By coupling CRISPR/Cas-mediated genome editing to other tools, such as Flow-FISH, novel insights have been gained into basic cellular processes, the way infections like SARS-CoV-2 rewire cellular metabolism, and the complex network of interactions of cis-regulatory elements and their target genes. Other potential applications could include screening for CRISPR repair efficiency by making use of template-specific probes, or assessing the effector function of tumor infiltrating lymphocyte products with Flow-FISH [17] after CRISPR-mediated genome editing [18]. However, while using e.g. Flow-FISH to sort for cells expressing the target or interacting gene can be useful, sorting should be done in an unbiased manner. Similarly, as the amount of data produced when performing such experiments is also of a great magnitude, data analysis should be carefully considered. For this, computerized models such as Mean Alterations Using Discrete Expression (MAUDE) could be employed [19].

Julian J. Freen-van Heeren: Conceptualization; investigation; writing – original draft; writing – review and editing; project administration; visualization.

The author declares no conflicts of interest.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
将 CRISPR 与 Flow-FISH 结合起来,研究 CRISPR 引起的基因组扰动。
自从聚类规则间隔短回文重复序列(CRISPR)-CRISPR相关(Cas)系统作为基因组编辑工具问世以来,研究基因功能及其对细胞功能的影响变得越来越容易。毫不奇怪,CRISPR/Cas 系统的最初描述者获得了 2020 年诺贝尔化学奖。与传统的基因组编辑工具(如转录激活子样效应核酸酶(TALENs)或锌指核酸酶(ZFNs))相比,CRISPR是一个用途更广的平台,可以很容易地调整以靶向新的感兴趣的基因。最近,CRISPR/Cas9系统编辑基因组背后的机制已在其他地方进行了详尽的综述[1]。简而言之,CRISPR 介导的基因组编辑至少取决于两个组成部分:(1) 具有内切酶活性的 Cas 蛋白;(2) 基于可变 ~20 碱基对核酸的靶向 crisprRNA(crRNA),用于定义感兴趣的靶点。根据所使用的 Cas 蛋白类型,还需要反式激活 RNA(tracrRNA)来激活核酸酶活性。gRNA 和 tracrRNA 通常合称为单导 RNA 或 sgRNA。此外,核酸酶活性只有在原位相邻动机(PAM)的背景下才会发生--PAM 是一种特定的 3-5 个核苷酸序列,对所使用的 Cas 分子具有特异性,从而进一步增强了靶向特异性。事实上,PAM 和基因特异性靶向 gRNA 共同确定了双链裂解的目标基因组位点。随后,低效的 DNA 修复机制会引入突变,在此过程中往往会使相关基因失效[2]。为确保基因敲除,还可以用两个特定的 gRNA 靶向感兴趣的基因,从而删除特定的(非)编码基因组信息[3]。CRISPR/Cas 介导的基因组编辑还可以利用供体修复模板引入特定的突变或部分基因替换[4]。然而,为了验证基因敲除或其效果,研究人员仍然经常依赖(基因组)测序数据,因为在测序之后,基因敲除细胞不再存活,也不能用于实验,只能提供基因组或 RNA 层面的信息。当基因敲除效率不理想时,除非进行了单细胞 RNA 测序,否则得出的数据集可能会被混淆。然而,这些类型的数据往往成本高昂,而且需要高水平的专业知识来分析。因此,利用其他工具扩展 CRISPR 工具箱,使基因改变或其对其他基因的影响可视化,是非常可取的。荧光原位杂交(FISH)就是一种适用于这一目的的技术。FISH 利用荧光标记的核酸探针特异性识别 DNA 序列,以确定感兴趣的基因座或特定的 mRNA 物种,从而研究感兴趣基因的表达。FISH 和 CRISPR 介导的基因组编辑已经结合起来,成为一种研究工具 [5]。此外,FISH 也适用于流式细胞仪(也称为流式荧光显微镜),可进行高通量和多参数测量,尤其是在使用荧光抗体检测 mRNA/核苷酸序列之外的蛋白质水平时 [6,7]。这种方法可以直接鉴定遗传扰动对端粒长度的影响,端粒长度反映了细胞的健康和寿命。在几项研究中,作者调查了控制端粒长度的因素。其中一项研究揭示了RAP1的作用,RAP1是一种众所周知的端粒结合蛋白,但功能不明。在 CRISPR/Cas9 介导的 RAP1 基因敲除后,通过 Flow-FISH 对端粒进行流式细胞术评估发现,RAP1 基因敲除细胞表现出更长的端粒[5]。不过,这也可以通过其他技术进行评估。事实上,CRISPR/Cas介导的基因组编辑与Flow-FISH相结合的真正好处在另一项研究中得到了体现,该研究的作者采用了一种基于CRISPR的筛选方法。在基于文库的基因敲除后,用端粒Flow-FISH对细胞进行筛选,选出端粒拥有率最高的5%群体和端粒拥有率最低的5%群体。他们发现SAMHD1是端粒长度的负调控因子,而胸腺嘧啶合成酶(TYMS)是正调控因子。有趣的是,给细胞补充胸苷(TYMS 的底物)也能有力地促进端粒的伸长。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cytometry Part A
Cytometry Part A 生物-生化研究方法
CiteScore
8.10
自引率
13.50%
发文量
183
审稿时长
4-8 weeks
期刊介绍: Cytometry Part A, the journal of quantitative single-cell analysis, features original research reports and reviews of innovative scientific studies employing quantitative single-cell measurement, separation, manipulation, and modeling techniques, as well as original articles on mechanisms of molecular and cellular functions obtained by cytometry techniques. The journal welcomes submissions from multiple research fields that fully embrace the study of the cytome: Biomedical Instrumentation Engineering Biophotonics Bioinformatics Cell Biology Computational Biology Data Science Immunology Parasitology Microbiology Neuroscience Cancer Stem Cells Tissue Regeneration.
期刊最新文献
Issue Information - TOC Volume 105A, Number 12, December 2024 Cover Image Autofluorescence lifetime flow cytometry rapidly flows from strength to strength. Flow cytometry-based method to detect and separate Mycoplasma hyorhinis in cell cultures. The consequence of mismatched buffers in purity checks when spectral cell sorting
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1